ATE401007T1 - Kleinkindernahrung mit proteasehemmer - Google Patents

Kleinkindernahrung mit proteasehemmer

Info

Publication number
ATE401007T1
ATE401007T1 AT04808740T AT04808740T ATE401007T1 AT E401007 T1 ATE401007 T1 AT E401007T1 AT 04808740 T AT04808740 T AT 04808740T AT 04808740 T AT04808740 T AT 04808740T AT E401007 T1 ATE401007 T1 AT E401007T1
Authority
AT
Austria
Prior art keywords
protease inhibitors
toddler food
infant nutrition
toddler
food
Prior art date
Application number
AT04808740T
Other languages
English (en)
Inventor
Laere Katrien Van
Bernardina Delsing
Christopher Beermann
Rene Raggers
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of ATE401007T1 publication Critical patent/ATE401007T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
AT04808740T 2004-11-26 2004-11-26 Kleinkindernahrung mit proteasehemmer ATE401007T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2004/000824 WO2006057551A1 (en) 2004-11-26 2004-11-26 Infant nutrition with protease inhibitor

Publications (1)

Publication Number Publication Date
ATE401007T1 true ATE401007T1 (de) 2008-08-15

Family

ID=34959837

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04808740T ATE401007T1 (de) 2004-11-26 2004-11-26 Kleinkindernahrung mit proteasehemmer

Country Status (6)

Country Link
US (3) US20080274945A1 (de)
EP (1) EP1811865B1 (de)
CN (1) CN101242748A (de)
AT (1) ATE401007T1 (de)
DE (1) DE602004015169D1 (de)
WO (1) WO2006057551A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
EP1800675B1 (de) * 2005-12-23 2011-05-18 N.V. Nutricia Zusammensetzung enthaltend mehrfach ungesättigte Fettsäuren, Proteine, Mangan und/oder Molybden und Nukleotide/Nukleoside, zur Behandlung von Demenz
US20110136732A1 (en) * 2005-12-23 2011-06-09 N.V. Nutricia Infant nutritional compositions for preventing obesity
EP1932437A1 (de) * 2006-12-15 2008-06-18 Nestec S.A. Kinderformel
EP1974734A1 (de) * 2007-03-28 2008-10-01 Nestec S.A. Probiotika zur Minderung des Risikos von Fettleibigkeit
RU2540538C2 (ru) * 2009-01-19 2015-02-10 Нестек С.А. Питательная композиция для младенцев
US8765152B2 (en) 2010-02-25 2014-07-01 Evonik Roehm Gmbh Pharmaceutical or neutraceutical formulation
NZ709245A (en) 2010-11-23 2016-11-25 Pantheryx Inc Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
EP2514435A1 (de) * 2011-04-19 2012-10-24 Nestec S.A. Säuglingsnahrung zur Verwendung bei der Prävention von kardiovaskulären Erkrankungen
HK1200727A1 (en) 2012-02-01 2015-08-14 奥拉姆德有限公司 Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
LT2975023T (lt) 2013-03-13 2018-08-10 Takeda Pharmaceutical Company Limited Guanidinbenzoinės rūgšties esterio junginys
US20160309768A1 (en) 2013-12-12 2016-10-27 Nestec S.A. Synthetic milk compositions for optimal growth and development and prevention of obesity in male and female infant and children
US9346776B2 (en) 2014-02-13 2016-05-24 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
US9428470B2 (en) 2014-02-13 2016-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
US12263192B2 (en) 2019-02-26 2025-04-01 Pantheryx, Inc. Compositions for management of disorders of the gastrointestinal tract
KR20240004268A (ko) * 2021-02-26 2024-01-11 팬더릭스 인코포레이티드 안정화된 초유 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491578A (en) * 1982-06-14 1985-01-01 Peikin Steven R Method of stimulating satiety in mammals
US4833128A (en) * 1984-12-28 1989-05-23 Neil Solomon Dietary supplement
WO1993010818A1 (en) * 1991-12-04 1993-06-10 New England Medical Center Hospitals, Inc. Infant formula and infant formula additives
DK0843972T3 (da) * 1996-11-20 2002-12-02 Nutricia Nv Næringsmiddelsammensætning, der indeholder fedtstoffer til behandling af stofskiftesygdomme
CN1273030C (zh) * 1998-10-16 2006-09-06 雀巢制品公司 缓慢消化的蛋白质及其用途
US6838431B2 (en) * 1999-07-27 2005-01-04 Pacific Health Laboratories, Inc. Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety
DE10108199A1 (de) * 2001-02-21 2002-08-22 Bosch Gmbh Robert Steckvorrichtung
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
AU2003228787A1 (en) * 2002-05-01 2003-11-17 Kemin Consumer Care, L.C. Composition and method for reducing post-prandial blood glucose
US6884454B2 (en) * 2002-10-21 2005-04-26 Julio Lionel Pimentel Appetite suppressing diet bar

Also Published As

Publication number Publication date
US20160175411A1 (en) 2016-06-23
CN101242748A (zh) 2008-08-13
US20120276214A1 (en) 2012-11-01
US20080274945A1 (en) 2008-11-06
EP1811865B1 (de) 2008-07-16
WO2006057551A1 (en) 2006-06-01
EP1811865A1 (de) 2007-08-01
DE602004015169D1 (de) 2008-08-28

Similar Documents

Publication Publication Date Title
ATE401007T1 (de) Kleinkindernahrung mit proteasehemmer
ZA202208159B (en) Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
ATE449522T1 (de) Kochvorrichtung
SG10201810390TA (en) Thermal processing susceptor
EP2012786A4 (de) Pyridonsulfonamide und pyridonsulfamide als mek-hemmer
MXPA05010706A (es) Uso de un inhibidor del transporte de acido biliar ileal (ibat) para el tratamiento o profilaxis del estrenimiento.
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
BRPI0517088A (pt) formulação de comprimido estável
NO20072524L (no) Flavonoid sukker addisjonsprodukter, fremgangsmate for fremstilling og anvendelse derav
WO2004101742A3 (en) Protease inhibitors for coronaviruses and sars-cov and the use thereof
TW200719113A (en) Dust-cleaning device for computes and method using the same with a computer fan
MY148723A (en) Use of pinolenic acid for the treatment of obesity
WO2007085775A3 (fr) Utilisation d'inhibiteurs de 15-lipoxygenase dans le traitement de l'obesite
TW200602073A (en) Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a DPP-IV mediated condition
TW200638950A (en) Dosage forms of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase inhibitors
DE602005024813D1 (de) Mehrzweckkassette zur einstellung einer mahlvorrichtung einer mechanischen oder elektrischen gewürzmühle oder einer vorrichtung zum zerbröseln von nahrungsmitteln
SG170796A1 (en) Methods for improving the pharmacokinetics of hiv integrase inhibitors
NO20072285L (no) S-mirtazapin for behandling av hetetokter
MX2009006507A (es) Nueva combinacion para usarse en el tratamiento de trastornos inflamatorios.
SG159538A1 (en) Apparatus and method for radiation processing of fluent food products
TN2011000214A1 (en) Combination of hsp90 and herceptin inhibitors
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
CL2013002375A1 (es) Dispositivo giratorio para ajustar la longitud efectiva de una pata de una mesa u otro articulo de mobiliario, que comprende un miembro inferior que, incluye al menos una rampa dirigida hacia abajo, separada de una segunda rampa de trinquete de pared, para formar un canal, y un miembro superior que incluye al menos un tope de parada para funcionar en el canal que se conforma entre las rampas .
TW200833336A (en) Method of treatment of obesity
ITRM20050542A1 (it) Procedimento ed apparecchio per il trasporto di prodotti piani.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties